Rezvoglar™ (insulin glargine-aglr) injection

3 mL (100 units/mL)

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Is the structure of Rezvoglar™ (insulin glargine‑aglr) and Basaglar® (insulin glargine) the same?

Rezvoglar has an identical amino acid sequence to that of Basaglar.

US_cFAQ_REZ032_STRUCTURE_VS_BASAGLAR
cFAQ
cFAQ
US_cFAQ_REZ032_STRUCTURE_VS_BASAGLAR
en-US

Structure of Rezvoglar

Rezvoglar™ (insulin glargine-aglr) 100 units/mL and Basaglar® (insulin glargine) 100 units/mL have an identical amino acid sequence.1,2

Rezvoglar has a different amino acid sequence to that of human insulin (Structure of Rezvoglar Compared With Human Insulin).1

Structure of Rezvoglar Compared With Human Insulin1

Position

Rezvoglar

Human Insulin

A21

Glycine

Asparagine

C-terminus of the beta chain

Addition of 2 arginines

NA

Abbreviations: NA = not applicable; Rezvoglar = Rezvoglar™ (insulin glargine-aglr) 100 units/mL.

References

1Rezvoglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

2Basaglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

Date of Last Review: May 04, 2022


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical